Identification of a new, unorthodox member of the MAGE gene family

Genomics

Volumn 59, Issue 2, 1999, Pages 161-167

  Põld, Mehis ^a   Zhou, Jin ^a   Chen, Grace L ^a   Hall, Jeffrey M ^c   Vescio, Robert A ^a,b   Berenson, James R ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Axys Pharmaceuticals Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PRIMER DNA; TUMOR ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; BONE MARROW; CHROMOSOME IDENTIFICATION; CHROMOSOME MAP; CHROMOSOME XP; GENE SEQUENCE; GENETIC LINKAGE; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER; MULTIGENE FAMILY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; TESTIS; TUMOR CELL; TUMOR IMMUNOLOGY;

EID: 0033566174     PISSN: 08887543     EISSN: None     Source Type: Journal    
DOI: 10.1006/geno.1999.5870     Document Type: Article

References (17)

1. Adams M. D., Kerlavage A. R., Fields L., Venter J. C. 3400 new expressed sequence tags identify diversity of transcripts in human brain. Nat. Genet. 4:1993;256-267.
2. Boël P., Wildmann C., Sensi M. L., Brasseur R., Renauld J. C., Coulie P., Boon R., van der Bruggen P. BAGE: A new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes. Cell. 2:1995;167-175.
3. Brinkmann U., Vasmatzis G., Byungkook L., Yerushalmi N., Essand M., Pastan I. PAGE-1, an X chromosome-linked GAGE-line gene that is expressed in normal and neoplastic prostate, testis, and uterus. Proc. Natl. Acad. Sci. USA. 95:1998;10757-10762.
4. De Plaen E., Arden K., Traversari C., Gaforio J. J., Szikora J-P., De Smet C., Brasseur F., van der Bruggen P., Lethe B., Lurquin C., Brasseur R., Chomez P., De Baker O., Canence W., Boon T. Structure, chromosomal location, and expression of 12 genes of the MAGE family. Immunogenetics. 40:1994;360-369.
5. Gartner S. M., Kaplan H. S. Long-term culture of human bone marrow cells. Proc. Natl. Acad. Sci. USA. 77:1980;4756-47569.
6. Gaugler B., Brouwenstijn N., Vantomme V., Szikora J-P., Van der Spek C. W., Patard J-J., Boon T., Schrier P., Van den Eynde B. J. A new gene coding for an antigen recognized by autologous cytolytic T lymphocytes on a human renal carcinoma. Immunogenetics. 44:1996;323-330.
7. Hu X., Chakraborty N. G., Sporn, Kurzman S. K., Ergin M. T., J. R., Mukherji B. Enhancement of cytolytic T lymphocyte precursor frequency in melanoma patients following immunization with the MAGE-1 peptide loaded antigen presenting cell-based vaccine. Cancer Res. 56:1996;2479-2483.
8. Hubank M., Schatz D. G. Identifying differences in mRNA expression by representational difference analysis of cDNA. Nucleic Acids Res. 22:1994;5640-5648.
9. Kocher D., Schultz-Tater E., Gudat F., Schaefer C., Casorati C., Juretic A., Williman T., Harder F., Heberer M., Spagnoli G. C. Identification and intracellular location of MAGE-3 gene product. Cancer Res. 55:1995;2236-2239.
10. Kozak M. At least six nucleotides preceding the AUG initiator codon enhance translation in mammalian cells. J. Mol. Biol. 196:1987;947-950.
11. Lethe B., Lucas S., Michaux L., Godelaine D., Serrano A., De Plaen E., Boon T. LAGE-1, a new gene with tumor specificity. Int. J. Cancer. 76:1998;903-908.
12. Lucas S., De Smet C., Arden K. C., Viars C. S., Lethe B., Lurquin C., Boon T. Identification of a new MAGE gene with tumor specific expression by representational difference analysis. Cancer Res. 58:1998;743-752.
13. Marchand M., Weynants P., Rankin E., Arienti F., Belli F., Rarmiani G., Cascinelli N., Bourlond A., Vanwijck R., Humblet Y. Tumor regression responses in melanoma patients treated with a peptide encoded by gene MAGE-3. Int. J. Cancer. 63:1995;883-885.
14. McCurdy D. K., Tai L-Q., Nguyen J., Wang Z., Yang H-M., Udar N., Naiem F., Concannon P., Gatti R. A. MAGE Xp-2: A member of the MAGE gene family isolated from an expression library using systemic lupus erythematosus sera. Mol. Genet. Metabol. 63:1998;3-13.
15. Mukherji B., Chakraborty N. G., Yamasaky S., Okino T., Yamase H., Sporn J. R., Kurzman S. K., Ergin M. T., Ozols J., Meehan J., Mauri F. Induction of antigen-specific cytolytic T cells in situ in human melanoma by immunization with synthetic peptide-pulsed autologous antigen presenting cells. Proc. Natl. Acad. Sci. USA. 92:1995;8078-8082.
16. Rettig M. B., Ma H. J., Vescio R. A., Põld M., Schiller G., Belson D., Savage A., Nishikubo C., Wu C., Fraser J., Said J. W., Berenson J. R. Kaposi's sarcoma-associated herpesvirus infection of bone marrow dendritic cells from multiple myeloma patients. Science. 276:1997;1851-1854.
17. Van den Eynde B. J., van der Bruggen P. T cell tumor antigens. Curr. Opin. Immunol. 9:1997;684-693.